IBB
ETF Biotechnology NASDAQ

iShares Biotechnology ETF

$166.83
-4.50 (-2.63%)
Fund Overview by iShares (BlackRock)

Tracks the Nasdaq Biotechnology Index with market-cap weighting. Large-cap biotech dominance from Amgen, Gilead, Regeneron, and Vertex, with a long tail of smaller clinical-stage companies.

AUM$7.8B
Expense Ratio0.44%
Holdings224
Dividend Yield0.2%
DistributionQuarterly
BenchmarkNasdaq Biotechnology Index
InceptionFeb 2001
ExchangeNASDAQ
Price Data
Open$170.67
Prev Close$171.33
Day Range$166.72 — $170.78
52W Range$107.43 — $179.64
52-Week Range
$107.43 $179.64
From 52W High
-7.1%
From 52W Low
+55.3%
Investment Calculator

See how much dividend income IBB could generate based on its current price of $166.83 and 0.2% yield. Adjust the amount to estimate your quarterly distributions.

$
Shares Purchased59
Amount Invested$9,842.97
Annual Income$19.69
Monthly Income$1.64

Based on current dividend yield of 0.2%. Actual distributions may vary. Past dividends do not guarantee future payments.

Biotechnology ETF Comparison
ETF Price Change Expense AUM Holdings Yield
IBB
iShares Biotechnology ETF
 $166.83 -2.63% 0.44% $7.8B 224 0.2%
XBI
SPDR S&P Biotech ETF
 $130.69 -3.08% 0.35% $6.5B 145 0.1%
ARKG
ARK Genomic Revolution ETF
 $28.15 -3.53% 0.75% $1.8B 35 0.0%
Top Biotechnology Stocks View all →
Stock Price Change Market Cap
ABBV
Abbvie Inc
 $213.76 +2.08% 372.39B
AMGN
Amgen Inc
 $330.33 -0.13% 179.23B
GILD
Gilead Sciences Inc
 $130.28 -0.17% 160.50B
VRTX
Vertex Pharmaceuticals Inc
 $429.32 -1.15% 114.32B
REGN
Regeneron Pharmaceuticals
 $641.69 +1.81% 73.89B
ALNY
Alnylam Pharmaceuticals Inc
 $293.86 -0.15% 38.43B
RVMD
Revolution Medicines Inc
 $149.94 +1.79% 30.97B
BIIB
Biogen Inc
 $190.56 -0.70% 28.63B
NTRA
Natera Inc
 $201.84 +2.96% 26.83B
UTHR
United Therapeutics Corp
 $566.80 -0.03% 24.36B
IBB FAQ
What is IBB?
IBB is the iShares Biotechnology ETF, an exchange-traded fund managed by iShares (BlackRock). It tracks the Nasdaq Biotechnology Index and holds 224 Biotechnology securities with an expense ratio of 0.44%.
What is the expense ratio of IBB?
IBB charges an annual expense ratio of 0.44%, which means you pay $44.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does IBB pay dividends?
Yes, IBB pays a 0.2% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $20.00 per year in dividend income.
What are the alternatives to IBB?
Other biotechnology ETFs include XBI, ARKG. Each offers different expense ratios, weighting methodologies, and number of holdings. Compare them in the ETF comparison table above to find the best fit for your portfolio.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
View List →

Last updated: May 16, 2026 at 9:45 PM ET